Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Wood

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
BMC Medical Research Methodology|November 11, 2016
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryKrystal Bergin, Elizabeth Moore, Zoe McQuilten, et al.
Transfusion|January 12, 2024
Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromesAllison Mo, Erica Wood, Jake Shortt, et al.
Environmental Science & Technology|March 18, 2023
Improved Decision Making for Water Lead Testing in U.S. Child Care Facilities Using Machine-Learned Bayesian NetworksRiley E Mulhern, A J Kondash, Ed Norman, et al.
Internal Medicine Journal|July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern eraDiva Baggio, Eliza Chung, Cameron Wellard, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2026
Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk GroupsGhassan Zammar, Bradley Augustson, Elizabeth Moore, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
A Participatory Science Approach to Evaluating Factors Associated with the Occurrence of Metals and PFAS in Guatemala City Tap WaterJennifer Hoponick Redmon, Riley E Mulhern, Edwin Castellanos, et al.
British Journal of Haematology|June 8, 2026
Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases RegistryKenneth J C Lim, Elham Ashrafi, Cameron Wellard, et al.
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.
Vox Sanguinis|February 12, 2021
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working GroupRuchika Goel, Evan M Bloch, France Pirenne, et al.
Vox Sanguinis|October 26, 2021
International Forum on Home-Based Blood Transfusion: ResponsesBriony Shaw, Erica Wood, Zoe McQuilten, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
BMC Medical Research Methodology|November 11, 2016
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryKrystal Bergin, Elizabeth Moore, Zoe McQuilten, et al.
Transfusion|January 12, 2024
Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromesAllison Mo, Erica Wood, Jake Shortt, et al.
Environmental Science & Technology|March 18, 2023
Improved Decision Making for Water Lead Testing in U.S. Child Care Facilities Using Machine-Learned Bayesian NetworksRiley E Mulhern, A J Kondash, Ed Norman, et al.
Internal Medicine Journal|July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern eraDiva Baggio, Eliza Chung, Cameron Wellard, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2026
Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk GroupsGhassan Zammar, Bradley Augustson, Elizabeth Moore, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
A Participatory Science Approach to Evaluating Factors Associated with the Occurrence of Metals and PFAS in Guatemala City Tap WaterJennifer Hoponick Redmon, Riley E Mulhern, Edwin Castellanos, et al.
British Journal of Haematology|June 8, 2026
Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases RegistryKenneth J C Lim, Elham Ashrafi, Cameron Wellard, et al.
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.
Vox Sanguinis|February 12, 2021
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working GroupRuchika Goel, Evan M Bloch, France Pirenne, et al.
Vox Sanguinis|October 26, 2021
International Forum on Home-Based Blood Transfusion: ResponsesBriony Shaw, Erica Wood, Zoe McQuilten, et al.
Pageof 5